Compare ARK Genomic Revolution ETF (ARKG) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares 1 3 Year Treasury Bond ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while iShares 1 3 Year Treasury Bond ETF trades at $81.9. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | SHY | |
|---|---|---|
Sector | Sector/Thematic | Fixed Income |
52-Week High | $43.57 | $83.18 |
52-Week Low | $23.09 | $81.84 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SHY trades at $81.88, down 0.04% with a bearish technical signal from moving averages. The ETF shows neutral momentum oscillators and uniform support/resistance at $82. Recent corporate actions include scheduled dividends of $0.24 per share through mid-2026, providing income stability amid flat price movement.
Outlook remains cautious due to technical bearishness and interest rate sensitivity. Opportunities include consistent dividend yields, while risks involve Federal Reserve policy shifts impacting bond ETFs. Investors should weigh income benefits against potential rate hike volatility in the fixed income sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
